デフォルト表紙
市場調査レポート
商品コード
1429506

高薬理活性医薬品の世界市場レポート 2024

HP (High Potency) APIs Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
高薬理活性医薬品の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

高薬理活性医薬品の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には9.3%の年間平均成長率(CAGR)で363億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、がん症例数の増加、精密医療の重視の高まり、高齢化人口の継続的な増加に関連している可能性があり、これらすべてが拡大の推進に寄与しています。予測期間中に予想される主な動向には、生産施設の拡大や合併・買収などの活動への戦略的重点、HPAPI生産を強化するための投資拡大への専念、APIの製造への人工知能(AI)の組み込みなどの戦略的重点が含まれます。環境的に持続可能な製造慣行を重視し、革新的な新製品の発売に注力しています。

高薬理活性医薬品市場の成長は、がんの症例数の増加と、それに伴う抗がん剤の売上の増加によって推進されています。がん罹患率の急増により、抗がん剤の研究開発が強化され、その結果、市場の需要が高まっています。世界保健機関による国際がん調査機関(IARC)の報告書によると、世界のがんの負担は2040年までに新たに2,950万人増加し、1,640万人が死亡すると予想されています。特に、がんによる死亡の70%はがん関連です。中低所得国で発生します。その結果、がんの罹患率の拡大により、高薬理活性医薬品市場の収益が増加すると予想されます。

がんケアと治療の強化を目的とした政府の取り組みにより、高薬理活性医薬品市場の将来の成長を推進する態勢が整っています。これらの取り組みには、がんと診断された個人のアクセス、手頃な価格、ケアの質を向上させるために政府が実施する政策、資金提供、プログラムが含まれます。がん治療における高薬理活性医薬品の重要性は、特定の分子経路を標的とし、それによって治療の有効性を高める能力にあります。その一例が、2023年9月にバイデン大統領によって発表された「がんムーンショット・イニシアチブ」の復活です。このイニシアチブは、疾病管理予防センター(CDC)の支援を受けて、25年以内にがんによる死亡率を半減させ、がんに対する包括的な支援を提供することを目指しています。生存者とその家族。その結果、がん治療と治療を改善するための政府の取り組みが高薬理活性医薬品市場の成長を推進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の高薬理活性医薬品市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 革新HPAPI
  • 汎用HPAPI
  • 世界の高薬理活性医薬品市場、合成タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 合成HPAPI
  • バイオテクノロジーHPAPI
  • 世界の高薬理活性医薬品市場、治療用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腫瘍学
  • ホルモン障害
  • 緑内障
  • その他の治療用途(呼吸器疾患、CVD、糖尿病、美容、勃起不全)

第7章 地域および国の分析

  • 世界の高薬理活性医薬品市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の高薬理活性医薬品市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 高薬理活性医薬品市場の競合情勢
  • 高薬理活性医薬品市場の企業プロファイル
    • Merck KGaA
    • Pfizer, Inc
    • Thermo Fisher Scientific, Inc
    • Teva Pharmaceuticals
    • Lonza Group AG

第31章 その他の大手および革新的な企業

  • Sanofi(EUROAPI)
  • Corden Pharma International
  • Dr. Reddy's Laboratories Ltd.
  • Siegfried Holding AG
  • Novartis
  • Roche India
  • Arlak Biotech(India)
  • Healthkind Labs Pvt. Ltd
  • Swisschem Healthcare Pvt. Ltd
  • Apikos Pharma
  • Kolaz Biotech
  • Cstone Pharma(China)
  • Carsgen Therapeutics(China)
  • Jw Therapeutics(China)
  • Beigene(China)

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14477

High-potency APIs denote substances that, at very minimal doses, elicit a biological response. Traditionally, examples of HPAPIs include cytotoxic substances and sex hormones such as estrogen. While highly potent active pharmaceutical ingredients (HP APIs) in the market remain effective at significantly lower dosage levels compared to standard APIs, their potency presents distinctive handling challenges.

The primary categories within the high-potency APIs market are innovative HPAPI and generic HPAPI. Various synthesis types, including synthetic HPAPI and biotech HPAPI, find application in therapeutic areas such as oncology, hormonal disorders, glaucoma, and other medical fields such as respiratory disorders, cardiovascular disease (CVD), diabetes, cosmetology, and erectile dysfunction. Glaucoma comprises a group of eye diseases affecting the optic nerve, crucial for maintaining good vision.

The HP (high potency) APIs market research report is one of a series of new reports from The Business Research Company that provides HP (high potency) APIs market statistics, including HP (high potency) APIs industry global market size, regional shares, competitors with an HP (high potency) APIs market share, detailed HP (high potency) APIs market segments, market trends and opportunities, and any further data you may need to thrive in the HP (high potency) APIs industry. This HP (high potency) APIs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hp (high potency) apis market size has grown strongly in recent years. It will grow from $23.39 billion in 2023 to $25.5 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historical period can be ascribed to a heightened demand for oncology therapies, a growing focus of pharmaceutical companies on the production of high-potency active pharmaceutical ingredients (HPAPIs), an upsurge in healthcare awareness and expenditure, robust economic growth in emerging markets, and a rise in government initiatives.

The hp (high potency) apis market size is expected to see strong growth in the next few years. It will grow to $36.38 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be linked to an increase in the number of cancer cases, a heightened emphasis on precision medicine, and the continuous growth of the ageing population, all contributing to driving the expansion. Major trends expected in the forecast period involve a strategic emphasis on activities such as expanding production facilities and engaging in mergers and acquisitions, a dedicated focus on augmenting investments to bolster HPAPI production, the incorporation of artificial intelligence (AI) in manufacturing APIs, an emphasis on environmentally sustainable manufacturing practices, and a concentration on launching new, innovative products.

The growth of the HP (high potency) APIs market is driven by the increasing number of cancer cases and the concurrent rise in sales of cancer drugs. The surge in cancer incidence is leading to heightened research and development efforts for anticancer drugs, consequently fueling the demand for the market. According to the International Agency for Research on Cancer (IARC) report by the World Health Organization, the global cancer burden is anticipated to witness an increase of 29.5 million new cases and 16.4 million deaths by 2040. Notably, 70% of cancer-related deaths occur in middle and low-income countries. As a result, the escalating prevalence of cancer is expected to boost revenues for the HP (high potency) APIs market.

Government initiatives aimed at enhancing cancer care and treatment are poised to drive the future growth of the HP (high potency) APIs market. These initiatives encompass policies, funding, and programs implemented by governments to enhance the accessibility, affordability, and quality of care for individuals diagnosed with cancer. The importance of High Potency (HP) APIs in cancer treatment lies in their ability to target specific molecular pathways, thereby enhancing the effectiveness of therapies. An example is the revival of the Cancer Moonshot Initiative unveiled by President Biden in September 2023. The initiative, supported by the Centers for Disease Control and Prevention (CDC), aims to halve the cancer death rate within 25 years and provide comprehensive support to cancer survivors and their families. Consequently, government initiatives to improve cancer care and treatment are propelling the growth of the HP (high potency) APIs market.

Companies operating in the HP (high potency) APIs market are adopting strategies such as expanding production facilities and engaging in mergers and acquisitions to maintain their competitive positions. In June 2022, MilliporeSigma, a global life science business based in the US, inaugurated a $65 million facility for the production of high-potency active pharmaceutical ingredients (HPAPI), with a specific focus on cancer treatments.

Major players in the HP (high potency) APIs market are actively pursuing strategic partnerships to drive market revenues. Collaborations offer various advantages, including access to new technology, expanded customer choice, global servicing capabilities, a collaborative global platform, and integrated services. In March 2023, CatSci Ltd., a UK-based provider of innovative process research and development services, partnered with AGC Pharma Chemicals Europe S.L.U. This collaboration enables customers to access a broad range of manufacturing technologies, including fluorination and bromination. It also facilitates AGC Pharma Chemicals' customers to benefit from expertise in state-of-the-art chemical development and analytical development.

In December 2021, SK Capital Partners, a US-based private investment firm, acquired a majority shareholding in SEQENS for an undisclosed amount. This strategic move positions SEQENS as a more potent and concentrated participant in the international markets for specialized ingredients and pharmaceutical solutions. Wavelength Pharmaceuticals, an existing SK Capital portfolio business that is a global manufacturer and developer of active medicinal ingredients, engaged in a combination concurrent with the acquisition. SEQENS, a France-based developer and manufacturer of custom High-Potency APIs, is a key player in this transformative development.

Major companies operating in the hp (high potency) apis market report are Merck KGaA, Pfizer, Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals, Lonza Group AG, Sanofi (EUROAPI), Corden Pharma International, Dr. Reddy's Laboratories Ltd., Siegfried Holding AG, Novartis, Roche India, Arlak Biotech (India), Healthkind Labs Pvt. Ltd., Swisschem Healthcare Pvt. Ltd., Apikos Pharma, Kolaz Biotech, Cstone Pharma (China), Carsgen Therapeutics (China), Jw Therapeutics (China), Beigene(China), Takeda Pharmaceuticals (Japan), Astellas Pharma Inc (Japan), Otsuka Pharmaceutical Co, Ltd (Japan), Legend Biotech Co (China), Abbott Laboratories, Vectura Group (U.K), Corex Logistics, Dokumeds, Medpace, Labcorp, Almedis (Russia), Neuca, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Tzmo, Eli Lilly And Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, Abbvie Inc., Hisun Usa Inc., Glaxosmithkline, Amega Biotech, Biomarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, Saudibio, Tabuk Pharmaceuticals, Cipla, Bayer, Adcock Ingram, Johnson & Johnson, Astrazeneca Pharmaceutical (Pty) Ltd., Eurolab, Ranbaxy (Sa) (Pty) Ltd.

North America was the largest region in the global HP (high potency) APIs market in 2023. Middle East is expected to be the fastest growing region in the HP (high potency) APIs market report during the forecast period. The regions covered in the hp (high potency) apis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hp (high potency) apis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The market consists of sales of cytotoxic compounds and sex hormones. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

HP (High Potency) APIs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hp (high potency) apis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hp (high potency) apis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hp (high potency) apis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Innovative HPAPI; Generic HPAPI
  • 2) By Synthesis Type: Synthetic HPAPI; Biotech HPAPI
  • 3) By Therapeutic Application: Oncology; Hormonal Disorder; Glaucoma; Other Therapeutic Applications
  • Companies Mentioned: Merck KGaA; Pfizer, Inc; Thermo Fisher Scientific, Inc; Teva Pharmaceuticals; Lonza Group AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. HP (High Potency) APIs Market Characteristics

3. HP (High Potency) APIs Market Trends And Strategies

4. HP (High Potency) APIs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global HP (High Potency) APIs Market Size and Growth

  • 5.1. Global HP (High Potency) APIs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global HP (High Potency) APIs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global HP (High Potency) APIs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. HP (High Potency) APIs Market Segmentation

  • 6.1. Global HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Innovative HPAPI
  • Generic HPAPI
  • 6.2. Global HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Synthetic HPAPI
  • Biotech HPAPI
  • 6.3. Global HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Hormonal Disorder
  • Glaucoma
  • Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

7. HP (High Potency) APIs Market Regional And Country Analysis

  • 7.1. Global HP (High Potency) APIs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global HP (High Potency) APIs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific HP (High Potency) APIs Market

  • 8.1. Asia-Pacific HP (High Potency) APIs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China HP (High Potency) APIs Market

  • 9.1. China HP (High Potency) APIs Market Overview
  • 9.2. China HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India HP (High Potency) APIs Market

  • 10.1. India HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan HP (High Potency) APIs Market

  • 11.1. Japan HP (High Potency) APIs Market Overview
  • 11.2. Japan HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia HP (High Potency) APIs Market

  • 12.1. Australia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia HP (High Potency) APIs Market

  • 13.1. Indonesia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea HP (High Potency) APIs Market

  • 14.1. South Korea HP (High Potency) APIs Market Overview
  • 14.2. South Korea HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe HP (High Potency) APIs Market

  • 15.1. Western Europe HP (High Potency) APIs Market Overview
  • 15.2. Western Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK HP (High Potency) APIs Market

  • 16.1. UK HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany HP (High Potency) APIs Market

  • 17.1. Germany HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France HP (High Potency) APIs Market

  • 18.1. France HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy HP (High Potency) APIs Market

  • 19.1. Italy HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain HP (High Potency) APIs Market

  • 20.1. Spain HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe HP (High Potency) APIs Market

  • 21.1. Eastern Europe HP (High Potency) APIs Market Overview
  • 21.2. Eastern Europe HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia HP (High Potency) APIs Market

  • 22.1. Russia HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America HP (High Potency) APIs Market

  • 23.1. North America HP (High Potency) APIs Market Overview
  • 23.2. North America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA HP (High Potency) APIs Market

  • 24.1. USA HP (High Potency) APIs Market Overview
  • 24.2. USA HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada HP (High Potency) APIs Market

  • 25.1. Canada HP (High Potency) APIs Market Overview
  • 25.2. Canada HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America HP (High Potency) APIs Market

  • 26.1. South America HP (High Potency) APIs Market Overview
  • 26.2. South America HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil HP (High Potency) APIs Market

  • 27.1. Brazil HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East HP (High Potency) APIs Market

  • 28.1. Middle East HP (High Potency) APIs Market Overview
  • 28.2. Middle East HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa HP (High Potency) APIs Market

  • 29.1. Africa HP (High Potency) APIs Market Overview
  • 29.2. Africa HP (High Potency) APIs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa HP (High Potency) APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa HP (High Potency) APIs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. HP (High Potency) APIs Market Competitive Landscape And Company Profiles

  • 30.1. HP (High Potency) APIs Market Competitive Landscape
  • 30.2. HP (High Potency) APIs Market Company Profiles
    • 30.2.1. Merck KGaA
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer, Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific, Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Teva Pharmaceuticals
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Lonza Group AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. HP (High Potency) APIs Market Other Major And Innovative Companies

  • 31.1. Sanofi (EUROAPI)
  • 31.2. Corden Pharma International
  • 31.3. Dr. Reddy's Laboratories Ltd.
  • 31.4. Siegfried Holding AG
  • 31.5. Novartis
  • 31.6. Roche India
  • 31.7. Arlak Biotech (India)
  • 31.8. Healthkind Labs Pvt. Ltd
  • 31.9. Swisschem Healthcare Pvt. Ltd
  • 31.10. Apikos Pharma
  • 31.11. Kolaz Biotech
  • 31.12. Cstone Pharma (China)
  • 31.13. Carsgen Therapeutics (China)
  • 31.14. Jw Therapeutics (China)
  • 31.15. Beigene(China)

32. Global HP (High Potency) APIs Market Competitive Benchmarking

33. Global HP (High Potency) APIs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The HP (High Potency) APIs Market

35. HP (High Potency) APIs Market Future Outlook and Potential Analysis

  • 35.1 HP (High Potency) APIs Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 HP (High Potency) APIs Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 HP (High Potency) APIs Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer